When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALNA - Allena Pharma up 11% premarket on revised design of reloxaliase study
Allena Pharmaceuticals Inc.
Thinly traded nano cap Allena Pharmaceuticals (NASDAQ:ALNA) is up 11% premarket on average volume on the heels of its announcement that the FDA has signed off, at least in principle, on a streamlined design for its second Phase 3 study evaluating reloxaliase for the potential treatment of hyperoxaluria (excess oxalate in the urine that can damage the kidneys). The changes should reduce the trial's length and cost.
More news on: Allena Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,